Helicobacter pylori first-line and rescue treatments in the presence of penicillin allergy. (Q41733681)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236423%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

Helicobacter pylori first-line and rescue treatments in the presence of penicillin allergy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236423%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Helicobacter pylori

1 reference

inferred from title

author

Miguel Fernandez-Bermejo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236423%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Alicia C Marín

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236423%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Adrian G McNicholl

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236423%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Manuel Castro-Fernández

6

object named as

Manuel Castro-Fernández

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236423%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Javier P Gisbert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236423%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Jesús Barrio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236423%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Inés Modolell

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236423%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Javier Molina-Infante

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236423%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Angeles Perez Aisa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236423%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Luis Rodrigo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236423%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Angel Cosme

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236423%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Jose Luis Gisbert

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236423%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Santiago Marcos

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236423%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

19 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236423%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

16 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236423%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236423%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236423%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

458-464

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25236423%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10620-014-3365-2

16 February 2020

exact match

0 references

cites work

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

Treatment of Helicobacter pylori infection 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

III Spanish Consensus Conference on Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

Helicobacter pylori first-line treatment and rescue options in patients allergic to penicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

The TETRA study: a prospective evaluation of Helicobacter pylori 'test-and-treat' strategy on 736 patients in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

Update on the efficacy of triple therapy for Helicobacter pylori infection and clarithromycin resistance rates in Spain (2007-2012)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

Tetracycline, metronidazole and amoxicillin-metronidazole combinations in proton pump inhibitor-based triple therapies are equally effective as alternative therapies against Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

High eradication rates of Helicobacter pylori infection with first- and second-line combination of esomeprazole, tetracycline, and metronidazole in patients allergic to penicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

"Rescue" regimens after Helicobacter pylori treatment failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

Levofloxacin : a review of its use as a high-dose, short-course treatment for bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

Levofloxacin based triple therapy as a second-line treatment after failure of Helicobacter pylori eradication with standard triple therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

In vitro activity of levofloxacin against Helicobacter pylori isolates from patients after treatment failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

Levofloxacin- versus metronidazole-based rescue therapy for H. pylori infection in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

Eradication of H. pylori infection in patients allergic to penicillin using triple therapy with a PPI, metronidazole and sitafloxacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

Sitafloxacin activity against Helicobacter pylori isolates, including those with gyrA mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

Levofloxacin: a review of its use in the treatment of bacterial infections in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

The evolution of Helicobacter pylori antibiotics resistance over 10 years in Beijing, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

Review article: rifabutin in the treatment of refractory Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3365-2

Population studies on drug hypersensitivities

21 January 2018

1 reference

12 December 2020

Worldwide H. pylori antibiotic resistance: a systematic review.

1 reference

12 December 2020

Susceptibility of Helicobacter pylori to mupirocin, oxazolidinones, quinupristin/dalfopristin and new quinolones

1 reference

12 December 2020

Helicobacter pylori resistance to metronidazole and to clarithromycin in Spain. A systematic review

1 reference

12 December 2020